.@​dawallach explains why the success of GLP-1s, which took decades to develop inside big pharma rather than a startup, shows just how difficult it is to turn d

.@​dawallach explains why the success of GLP-1s, which took decades to develop inside big pharma rather than a startup, shows just how difficult it is to turn drug ideas into treatments, even with AI: D.A.: "The bottleneck is not ideas... The challenge right now, even before AI, was that we have a…